Thanks for logging in.

You can now click/tap WATCH to start the live stream.

Thanks for logging in.

You can now click/tap LISTEN to start the live stream.

Thanks for logging in.

You can now click/tap LATEST NEWS to start the live stream.

LISTEN
Watch
on air now

Create a 4BC account today!

You can now log in once to listen live, watch live, join competitions, enjoy exclusive 4BC content and other benefits.


Joining is free and easy.

You will soon need to register to keep streaming 4BC online. Register an account or skip for now to do it later.

Advertisement
Advertisement
Advertisement

Diabetes drug Ozempic is not approved for weight loss, but this trend is leaving diabetics without

Peter Fegan

University of Sydney Associate Lecturer Pharmacy Practice Andrew Bartlett joins the program to explain the rising use of this diabetes drug by Australian consumers looking to lose weight and the dangers associated with it. Dan and Andrew talk about how this rise is seeing shortages for diabetics in need of it and what regulators need to do to address this issue.

Download this podcast here

Peter Fegan
Advertisement